Valneva SE (VALN) Enterprise Value (2020 - 2026)
Valneva SE's (VALN) quarterly Enterprise Value came in at -$123.2 million in Q1 2026, up 30.37% year-on-year from -$94.5 million in Q1 2025, and up 3.45% quarter-over-quarter from -$127.6 million in Q4 2025.
Valneva SE (VALN) Enterprise Value (2020 - 2026) Analysis & Trends
Valneva SE has disclosed Enterprise Value across 7 years of filings, most recently posting -$123.2 million for Q1 2026.
- Enterprise Value for Q1 2026 came in at -$123.2 million, up 30.37% year-over-year; the trailing twelve-month figure through Mar 2026 was -$123.2 million (up 30.37% YoY), and the FY2025 annual result was -$127.6 million, up 29.55% from the prior year.
- Enterprise Value came in at -$123.2 million for Q1 2026 at Valneva SE, up from -$127.6 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$312011.7 in Q2 2023 to a low of -$389.0 million in Q1 2022.
- The 5-year median for Enterprise Value is -$181.2 million (2024), against an average of -$207.3 million.
- Across the five-year window, Enterprise Value surged 99.91% in 2023 and sank 45256.32% in 2024, its largest moves.
- Valneva SE's Enterprise Value stood at -$292.3 million in 2022, then soared by 53.6% to -$135.7 million in 2023, then sank by 33.56% to -$181.2 million in 2024, then increased by 29.55% to -$127.6 million in 2025, then gained by 3.45% to -$123.2 million in 2026.
- The last three Enterprise Value figures came in at -$123.2 million (Q1 2026), -$127.6 million (Q4 2025), and -$167.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -584.73 Mn |
| 10 | Valneva SE | 167.33 Mn | 44.10 Mn | 5.08 Mn | -123.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -123.24 Mn |
| Dec 31, 2025 | -127.64 Mn |
| Sep 30, 2025 | -167.76 Mn |
| Jun 30, 2025 | -184.08 Mn |
| Mar 31, 2025 | -177.00 Mn |
| Dec 31, 2024 | -181.19 Mn |
| Sep 30, 2024 | -171.65 Mn |
| Jun 30, 2024 | -141.52 Mn |
| Mar 31, 2024 | -191.89 Mn |
| Dec 31, 2023 | -135.65 Mn |
| Sep 30, 2023 | -311.92 Mn |
| Jun 30, 2023 | -312,011.68 |
| Mar 31, 2023 | -307.55 Mn |
| Dec 31, 2022 | -292.33 Mn |
| Sep 30, 2022 | -263.20 Mn |
| Jun 30, 2022 | -358.77 Mn |
| Mar 31, 2022 | -389.05 Mn |
| Dec 31, 2021 | -396.60 Mn |
| Sep 30, 2021 | -241.04 Mn |
| Jun 30, 2021 | -397.13 Mn |